Nexalin Technology (NXL) Debt Ratio (2021)

Nexalin Technology (NXL) recorded quarterly Debt Ratio of 0.08 in Q4 2021.

Nexalin Technology (NXL) Debt Ratio (2021) Analysis & Trends

Nexalin Technology's Debt Ratio history runs 1 years deep, the most recent figure standing at 0.08 for Q4 2021.

In Q4 2021, Debt Ratio changed N/A year-over-year to 0.08; the TTM figure through Dec 2021 stood at 0.08 (changed N/A YoY), while the FY2021 annual figure was 0.08, changed N/A from the prior year.
Debt Ratio was 0.08 for Q4 2021 at Nexalin Technology.
In the past five years, Debt Ratio ranged from a high of 0.08 in Q4 2021 to a low of 0.08 in Q4 2021.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	0.31
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	0.32
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	0.31
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	0.04
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.30
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	0.27
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	0.18
10	Nexalin Technology	7.82 Mn	5.11 Mn	13,133.00	-

Historic Data

Download Data

Date	Value
Dec 31, 2021	0.08